Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
AAZZUR is a fintechs company founded on a strong desire to make banking intelligent, individual and interconnected. It is reinventing the way banks are built, and its data can be used to increase monetization, satisfaction and retention. This company was founded 18 months ago, but in the last month, it was contacted by fintechs, banks and one insurance company to help them with their problems. AAZZUR provides tools for common functions for the banking space. Its entrepreneurial team has a depth of experience, and the company has been to one of the world-leading accelerators, techstars. Now, it is looking to work together with banks, and its team has developed a neo-bank offering in record time that they are going to be soft-launched soon.
days to go:
Expired
investment:
£400,991
Doc2UK is a specialist UK medical recruitment and candidate support platform. Based in London, the platform places qualified doctors in the National Health Scheme (NHS) roles around the United Kingdom. The British Medical Association (2018) reported that patient care is at risk due to a critical shortage of doctors across multiple medical disciplines. At present, the UK only has 24 medical schools to fill this gap, whilst India, in comparison, has 468 medical schools, with 68,000 doctors graduating each year. Moreover, uncertainty about the status of EU nationals after Brexit, changes to immigration policies, and the impact of changing language testing requirements for international nurses have made this crisis worse. This situation necessitates recruiting doctors from overseas an important endeavour. This is where Doc2UK aims to become a key player and ensure that lack of medical personnel doesn't disrupt any medical services. The company is seeking an investment of up to £300,000 which will be used to develop the platform with more features, expand the team, marketing and sales.
days to go:
Expired
investment:
Withheld
An app to help local independent businesses gain more exposure on the High Street. Sizzl will create bespoke marketing by using cinematography to tell stories for locals in the area to view on their smartphones. Investment will provide Sizzl with the infrastructure for a monthly subscription payment system and initial marketing to attract small businesses.
days to go:
Expired
investment:
£25,490
Peliwica Insurance is set up to disrupt the current rural, equine, and agriculture insurance broker markets. It is a new Insuretech business that was launched in 2018. In the same year, the company gained its first FCA Approval and the Lloyds CoverHolder status that held the key enablers to launch this business. Peliwica Insurance is trading with 10 Brokers with a £100m premium opportunity. With its upcoming mobile application and devised white-labelled D2C platforms, the company will be able to allow brokers to access new product markets and customers more effectively.
days to go:
Expired
investment:
£75,980
Extra Virgin Avocado Oil for those that live busy lifestyles but enjoy healthy snacking. South Press Co's avocado oil is cold-pressed and derived from the high-grade African avocados. Their oil is available in more than 500 Tesco stores and is sold on Amazon. Since launching in 2016, more than 375,000 bottles have been sold to date.
The company is now expanding their business and using their oil in crisps products, dubbed LENTILPOPS®, the first crisps brand in the UK to be made using avocado oil. This new range will contain 60% less fat compared with competing products and will be vegan and gluten, soy and lactose-free. South Press Co will also be launching their brand in the US via an e-commerce platform in January 2019, with distribution to physical retailers by the summer.
days to go:
Expired
investment:
£158,530
Race Space have created an endurance event directory for the 21st century that is designed to uncomplicate the online experience of finding and entering events.
days to go:
Expired
investment:
£111,583
